Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pacific Holding Company is a private investment vehicle and holding company primarily owned by billionaire David H. Murdock. While not a traditional biotechnology company, it is a significant player in the life sciences sector through its development and ownership of the North Carolina Research Campus (NCRC), a $1.5 billion life sciences research center. The company has historically held major stakes in global health and nutrition-focused entities, most notably the Dole Food Company and Castle & Cooke. Its business model focuses on long-term investments in agriculture, real estate, and scientific research aimed at improving human health and longevity through nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pacific Holding Company.